欢迎使用我们的服务！
限时优惠，立即购买享受折扣
24小时客服在线，随时为您服务
优质产品，值得信赖

印度仿制药专卖店
登录
顶 置

文章列表

Merck & Co.’s Lipfendra Brings First Oral PCSK9 To Market

2026-07-19
Revital Brings a Fresh Perspective to India’s Conversation Around Everyday Fatigue

2026-07-19
Bristol Myers Squibb to Report Results for Second Quarter 2026 on July 30, 2026

2026-07-19
Biocon Announces Publication of Pivotal Clinical Data Supporting Effectiveness of Yesafili™, a Biosimilar to Eylea® (Aflibercept)

2026-07-19
Alzheimer’s AAIC Video Interview: Eisai Looks To Extend Leqembi Lead With Tau-Targeting Combo

2026-07-19
EU: New GMP Implementing Regulations for Veterinary Medicinal Products

2026-07-18
Merck & Co.’s Lipfendra Brings First Oral PCSK9 To Market

2026-07-18
On behalf of Respighi BidCo S.p.A – Press Release pursuant to Article 36 of the Issuers’ Regulation

2026-07-18
GSK’s Camlipixant Scrapped After Coughing Up Mixed Results

2026-07-18
Biocon Malaysia Receives EMA Approval for New Drug Product Fill Finish Unit for Insulins

2026-07-18
Aurobindo Receives FDA Approval for Cephalexin For Oral Suspension USP, 125 mg/5 mL and 250 mg/5 mL

2026-07-17
Approval of the Issuer’s statement pursuant to art 103 para 3 of Leg Decree no. 58/1998, in connection with the public VTO for all the ordinary shares of Recordati Spa launched by Respighi BidCo Spa

2026-07-17